Triazolam

Triazolam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Triazolam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.

Triazolam comes as a tablet to take by mouth. It is usually taken as needed at bedtime but not with or shortly after a meal. Triazolam may not work well if it is taken with food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take triazolam exactly as directed.

You will probably become very sleepy soon after you take triazolam and will remain sleepy for some time after you take the medication. Plan to go to bed right after you take triazolam and to stay in bed for 7 to 8 hours. Do not take triazolam if you will be unable to remain asleep for 7 to 8 hours after taking the medication. If you get up too soon after taking triazolam, you may experience memory problems.

Your sleep problems should improve within 7 to 10 days after you start taking triazolam. Call your doctor if your sleep problems do not improve during this time, if they get worse at any time during your treatment, or if you notice any changes in your thoughts or behavior.

Triazolam should normally be taken for short periods of time (usually 7 to 10 days). You should not take triazolam for more than 2 to 3 weeks without talking to your doctor. If you take triazolam for 7 to 10 days or longer, triazolam may not help you sleep as well as it did when you first began to take the medication, and you may wake up more easily during the last third of the night. You may also start to feel anxious or nervous during the day, and you may develop dependence ('addiction'; a need to continue taking the medication) on triazolam. Talk to your doctor about the risks of taking triazolam for 2 weeks or longer.

You may have more difficulty falling asleep or staying asleep on the first few nights after you stop taking triazolam than you did before you started taking the medication. This is normal and usually gets better without treatment after one or two nights.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with triazolam and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking triazolam,

• tell your doctor and pharmacist if you are allergic to triazolam; other benzodiazepines; any other medications; or any of the ingredients in triazolam tablets. Ask your pharmacist for a list of the ingredients.

• tell your doctor if you are taking any of the following medications: antifungal medications including itraconazole (Onmel, Sporanox) and ketoconazole (Nizoral); certain medications for human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) including indinavir (Crixivan), lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Invirase); and nefazodone. Your doctor will probably tell you not to take triazolam.

• tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: amiodarone (Nexterone, Pacerone); certain antibiotics such as clarithromycin (Biaxin, in Prevpac), erythromycin (Erythrocin, E-mycin), telithromycin (Ketek), and troleandomycin (TAO) (not available in the US); antidepressants; certain antifungal medications; antihistamines; certain calcium channel blockers such as diltiazem (Cardizem, Dilacor, Tiazac, others), nicardipine (Cardene), nifedipine (Adalat, Afeditab, Procardia), and verapamil (Calan, Verelan); cyclosporine (Gengraf, Neoral, Sandimmune); ergotamine (Cafergot, Ergomar, Migranal, others); certain histamine-2 receptor blockers (H2 blockers) such as cimetidine (Tagamet) and ranitidine (Zantac); hormonal contraceptives (birth control pills, patches, rings, implants, or injections); isoniazid (Laniazid, in Rifamate, in Rifater); medications for anxiety, colds or allergies, mental illness, or seizures; muscle relaxants; sedatives; certain selective serotonin reuptake inhibitors (SSRIs) such as fluvoxamine (Luvox), paroxetine (Brisdelle, Paxil, Pexeva), and sertraline (Zoloft); other sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with triazolam, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

• tell your doctor if you have ever thought about killing yourself or tried to do so, and if you have or have ever had any condition that affects your breathing, sleep apnea (condition in which a person briefly stops breathing many times during the night), seizures, or kidney or liver disease.

• tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking triazolam, call your doctor immediately. Triazolam may harm the fetus.

• talk to your doctor about the safe use of triazolam if you are 65 years of age or older. Older adults should usually take lower doses of triazolam because higher doses may not be more effective and are more likely to cause serious side effects.

• if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking triazolam.

• you should know that triazolam may make you drowsy during the daytime, may decrease your mental alertness, and may increase the risk that you could fall. Take extra care to be sure you do not fall, especially if you get out of bed in the middle of the night. Do not drive a car or operate machinery until you know how this medication affects you.

• you should know that some people who took medications for sleep got out of bed and drove their cars, prepared and ate food, had sex, made phone calls, or were involved in other activities while partially asleep. After they woke up, these people were usually unable to remember what they had done. Call your doctor right away if you find out that you have been driving or doing anything else while you were sleeping.

• you should know that your mental health may change in unexpected ways while you are taking this medication. It is hard to tell if these changes are caused by triazolam or if they are caused by physical or mental illnesses that you already have or suddenly develop. Tell your doctor right away if you experience any of the following symptoms: aggressiveness, strange or unusually outgoing behavior, hallucinations (seeing things or hearing voices that do not exist), feeling as if you are outside of your body, memory problems, difficulty concentrating, slowed speech or movements, new or worsening depression, thinking about killing yourself, confusion, and any other changes in your usual thoughts, mood, or behavior. Be sure that your family knows which symptoms may be serious so that they can call the doctor if you are unable to seek treatment on your own.

Do not eat grapefruit or drink grapefruit juice while taking this medication.

Triazolam should only be taken at bedtime. If you did not take triazolam at bedtime and you are unable to fall asleep, you may take triazolam if you will be able to remain in bed for 7 to 8 hours afterward. Do not take triazolam if you are not ready to go to sleep right away and stay asleep for at least 7 to 8 hours.

• Triazolam may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • drowsiness

  • dizziness

  • lightheadedness

  • headache

  • problems with coordination

  • nervousness

  • tingling of the skin

  • nausea

  • vomiting

• Some side effects can be serious. If you experience any of these symptoms or those listed in the SPECIAL PRECAUTIONS or IMPORTANT WARNING sections, call your doctor immediately or get emergency medical help:

  • rash

  • hives

  • itching

  • swelling of the eyes, face, lips, tongue, or throat

  • feeling that the throat is closing

  • difficulty breathing or swallowing

  • hoarseness

• Triazolam may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

• If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Keep triazolam in a safe place so that no one else can take it accidentally or on purpose. Keep track of how many capsules are left so you will know if any are missing.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

• extreme drowsiness

• confusion

• problems with coordination

• slurred speech

• slow or difficult breathing

• seizures

• coma (loss of consciousness for a period of time)

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to triazolam.

Do not let anyone else take your medication. Triazolam is a controlled substance. Prescriptions may be refilled only a limited number of times; ask your pharmacist if you have any questions.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug	Interaction
Montelukast	Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Triazolam.
Leflunomide	Leflunomide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Leflunomide.
Delavirdine	Delavirdine The metabolism of Triazolam can be decreased when combined with Delavirdine.
Nevirapine	Nevirapine The metabolism of Triazolam can be decreased when combined with Nevirapine.
Atorvastatin	Atorvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Atorvastatin.
Dolasetron	Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Triazolam.
Alendronate	Alendronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Triazolam.
Aminophylline	Aminophylline The therapeutic efficacy of Triazolam can be decreased when used in combination with Aminophylline.
Cilostazol	Cilostazol Triazolam may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Clopidogrel	Clopidogrel The metabolism of Triazolam can be decreased when combined with Clopidogrel.
Diphenoxylate	Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Triazolam.
Erythromycin and Sulfisoxazole	Erythromycin and Sulfisoxazole The serum concentration of Triazolam can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives)	Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Triazolam which could result in a higher serum level.
Fenofibrate	Fenofibrate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Fenofibrate.
Guanfacine	Guanfacine The risk or severity of adverse effects can be increased when Triazolam is combined with Guanfacine.
Magnesium Hydroxide	Magnesium Hydroxide Triazolam may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate	Mycophenolate Triazolam may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Nafarelin	Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Triazolam.
Naratriptan	Naratriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Naratriptan.
Olsalazine	Olsalazine Olsalazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Paregoric	Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Triazolam.
Pentazocine	Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Triazolam.
Potassium	Potassium Potassium may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone	Prednisone Prednisone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ranitidine	Ranitidine The serum concentration of Triazolam can be increased when it is combined with Ranitidine.
Reserpine	Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Triazolam.
Rizatriptan	Rizatriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Rizatriptan.
Sumatriptan	Sumatriptan The risk or severity of adverse effects can be increased when Sumatriptan is combined with Triazolam.
Tacrolimus	Tacrolimus The metabolism of Triazolam can be decreased when combined with Tacrolimus.
Tizanidine	Tizanidine The risk or severity of adverse effects can be increased when Tizanidine is combined with Triazolam.
Triamcinolone	Triamcinolone The metabolism of Triazolam can be increased when combined with Triamcinolone.
Zolmitriptan	Zolmitriptan The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Triazolam.
Ampicillin Injection	Ampicillin Injection Ampicillin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Doxycycline Injection	Doxycycline Injection Doxycycline may decrease the excretion rate of Triazolam which could result in a higher serum level.
Fluconazole Injection	Fluconazole Injection The metabolism of Triazolam can be decreased when combined with Fluconazole.
Foscarnet Injection	Foscarnet Injection Foscarnet may decrease the excretion rate of Triazolam which could result in a higher serum level.
Hydromorphone Injection	Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Triazolam.
Levofloxacin Injection	Levofloxacin Injection Triazolam may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection	Meperidine Injection The risk or severity of adverse effects can be increased when Meperidine is combined with Triazolam.
Metoclopramide Injection	Metoclopramide Injection The risk or severity of sedation can be increased when Triazolam is combined with Metoclopramide.
Metronidazole Injection	Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Triazolam.
Morphine Injection	Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Triazolam.
Pamidronate Injection	Pamidronate Injection Pamidronic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Vancomycin Injection	Vancomycin Injection Triazolam may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection	Zidovudine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Triazolam.
Altretamine	Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Triazolam.
Cefuroxime	Cefuroxime Cefuroxime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cyclosporine	Cyclosporine The metabolism of Triazolam can be decreased when combined with Cyclosporine.
Ondansetron	Ondansetron The risk or severity of adverse effects can be increased when Triazolam is combined with Ondansetron.
Granisetron	Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Triazolam.
Torsemide	Torsemide Torasemide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine	Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Triazolam.
Alosetron	Alosetron The risk or severity of adverse effects can be increased when Triazolam is combined with Alosetron.
Entacapone	Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Triazolam.
Eprosartan	Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Triazolam.
Meloxicam	Meloxicam Meloxicam may decrease the excretion rate of Triazolam which could result in a higher serum level.
Oxcarbazepine	Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Triazolam.
Pantoprazole	Pantoprazole Pantoprazole may decrease the excretion rate of Triazolam which could result in a higher serum level.
Risedronate	Risedronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Triazolam.
Temozolomide	Temozolomide Temozolomide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Zaleplon	Zaleplon The risk or severity of adverse effects can be increased when Triazolam is combined with Zaleplon.
Anakinra	Anakinra The metabolism of Triazolam can be increased when combined with Anakinra.
Desloratadine	Desloratadine The risk or severity of adverse effects can be increased when Triazolam is combined with Desloratadine.
Linezolid	Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Triazolam.
Trimipramine	Trimipramine The risk or severity of adverse effects can be increased when Trimipramine is combined with Triazolam.
Etanercept Injection	Etanercept Injection The metabolism of Triazolam can be increased when combined with Etanercept.
Glycopyrrolate	Glycopyrrolate Triazolam may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil	Modafinil The metabolism of Triazolam can be increased when combined with Modafinil.
Perindopril	Perindopril Perindopril may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tenofovir	Tenofovir Tenofovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Sirolimus	Sirolimus The serum concentration of Triazolam can be increased when it is combined with Sirolimus.
Dutasteride	Dutasteride The metabolism of Dutasteride can be decreased when combined with Triazolam.
Eplerenone	Eplerenone Eplerenone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram	Escitalopram The risk or severity of adverse effects can be increased when Triazolam is combined with Escitalopram.
Zonisamide	Zonisamide Triazolam may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
Adalimumab Injection	Adalimumab Injection The metabolism of Triazolam can be increased when combined with Adalimumab.
Aripiprazole	Aripiprazole The risk or severity of adverse effects can be increased when Triazolam is combined with Aripiprazole.
Atomoxetine	Atomoxetine The risk or severity of adverse effects can be increased when Atomoxetine is combined with Triazolam.
Dexmethylphenidate	Dexmethylphenidate The risk or severity of adverse effects can be increased when Triazolam is combined with Dexmethylphenidate.
Atazanavir	Atazanavir Atazanavir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Almotriptan	Almotriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Almotriptan.
Eletriptan	Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Triazolam.
Mefloquine	Mefloquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Triazolam.
Rosuvastatin	Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Rosuvastatin.
Vardenafil	Vardenafil The metabolism of Triazolam can be decreased when combined with Vardenafil.
Aprepitant	Aprepitant The metabolism of Triazolam can be decreased when combined with Aprepitant.
Emtricitabine	Emtricitabine Emtricitabine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Memantine	Memantine Triazolam may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil	Tadalafil Tadalafil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Frovatriptan	Frovatriptan The risk or severity of adverse effects can be increased when Triazolam is combined with Frovatriptan.
Progesterone	Progesterone The metabolism of Triazolam can be decreased when combined with Progesterone.
Apomorphine Injection	Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Triazolam.
Infliximab Injection	Infliximab Injection The metabolism of Triazolam can be increased when combined with Infliximab.
Protriptyline	Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Triazolam.
Duloxetine	Duloxetine The risk or severity of adverse effects can be increased when Triazolam is combined with Duloxetine.
Norethindrone	Norethindrone The metabolism of Triazolam can be decreased when combined with Norethisterone.
Tinidazole	Tinidazole Triazolam may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium	Trospium Triazolam may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Cefditoren	Cefditoren Cefdinir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cyanocobalamin Injection	Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Erlotinib	Erlotinib The metabolism of Triazolam can be decreased when combined with Erlotinib.
Eszopiclone	Eszopiclone The risk or severity of CNS depression can be increased when Triazolam is combined with Eszopiclone.
Ganciclovir	Ganciclovir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Ganciclovir.
Ribavirin	Ribavirin Ribavirin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Solifenacin	Solifenacin Triazolam may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Valganciclovir	Valganciclovir Triazolam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole	Voriconazole The metabolism of Triazolam can be decreased when combined with Voriconazole.
Adefovir	Adefovir Adefovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dextroamphetamine	Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Triazolam.
Sodium Oxybate	Sodium Oxybate Triazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Ibandronate	Ibandronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Triazolam.
Isocarboxazid	Isocarboxazid The risk or severity of adverse effects can be increased when Triazolam is combined with Isocarboxazid.
Ramelteon	Ramelteon The risk or severity of adverse effects can be increased when Triazolam is combined with Ramelteon.
Darifenacin	Darifenacin Triazolam may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl	Fentanyl The risk or severity of adverse effects can be increased when Fentanyl is combined with Triazolam.
Pregabalin	Pregabalin The therapeutic efficacy of Triazolam can be increased when used in combination with Pregabalin.
Phenylephrine	Phenylephrine The risk or severity of hypertension can be decreased when Triazolam is combined with Phenylephrine.
Felbamate	Felbamate The risk or severity of adverse effects can be increased when Triazolam is combined with Felbamate.
Ranolazine	Ranolazine Ranolazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Abatacept Injection	Abatacept Injection The metabolism of Triazolam can be increased when combined with Abatacept.
Rasagiline	Rasagiline The risk or severity of adverse effects can be increased when Triazolam is combined with Rasagiline.
Imatinib	Imatinib The metabolism of Triazolam can be decreased when combined with Imatinib.
Sitagliptin	Sitagliptin Triazolam may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline	Varenicline Triazolam may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib	Gefitinib The metabolism of Triazolam can be decreased when combined with Gefitinib.
Albuterol	Albuterol Triazolam may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone	Paliperidone The risk or severity of adverse effects can be increased when Triazolam is combined with Paliperidone.
Clofarabine Injection	Clofarabine Injection Clofarabine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Lubiprostone	Lubiprostone Triazolam may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Pemetrexed Injection	Pemetrexed Injection Triazolam may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate	Dimenhydrinate The risk or severity of adverse effects can be increased when Triazolam is combined with Dimenhydrinate.
Nabilone	Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Sorafenib	Sorafenib The metabolism of Triazolam can be decreased when combined with Sorafenib.
Sunitinib	Sunitinib The metabolism of Sunitinib can be decreased when combined with Triazolam.
Dronabinol	Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Lapatinib	Lapatinib The metabolism of Lapatinib can be decreased when combined with Triazolam.
Levocetirizine	Levocetirizine The risk or severity of adverse effects can be increased when Triazolam is combined with Levocetirizine.
Pegaptanib Injection	Pegaptanib Injection Triazolam may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib	Dasatinib The metabolism of Dasatinib can be decreased when combined with Triazolam.
Armodafinil	Armodafinil The metabolism of Triazolam can be increased when combined with Armodafinil.
Azacitidine Injection	Azacitidine Injection Triazolam may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Ivermectin	Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Triazolam.
Temsirolimus	Temsirolimus The serum concentration of Triazolam can be increased when it is combined with Temsirolimus.
Lenalidomide	Lenalidomide Lenalidomide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Raltegravir	Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Raltegravir.
Budesonide	Budesonide The metabolism of Triazolam can be increased when combined with Budesonide.
Chloramphenicol Injection	Chloramphenicol Injection The metabolism of Triazolam can be decreased when combined with Chloramphenicol.
Desmopressin	Desmopressin Desmopressin may decrease the excretion rate of Triazolam which could result in a higher serum level.
OnabotulinumtoxinA Injection	OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Triazolam.
RimabotulinumtoxinB Injection	RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triazolam.
Doripenem Injection	Doripenem Injection Triazolam may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection	Arsenic Trioxide Injection Triazolam may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine	Desvenlafaxine The risk or severity of adverse effects can be increased when Triazolam is combined with Desvenlafaxine.
Cevimeline	Cevimeline Cevimeline may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tretinoin	Tretinoin The metabolism of Triazolam can be decreased when combined with Tretinoin.
Certolizumab Injection	Certolizumab Injection The metabolism of Triazolam can be increased when combined with Certolizumab pegol.
Ixabepilone Injection	Ixabepilone Injection The serum concentration of Triazolam can be increased when it is combined with Ixabepilone.
Irinotecan Injection	Irinotecan Injection The metabolism of Triazolam can be decreased when combined with Irinotecan.
Daptomycin Injection	Daptomycin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Triazolam.
Praziquantel	Praziquantel The metabolism of Praziquantel can be decreased when combined with Triazolam.
Methylnaltrexone Injection	Methylnaltrexone Injection Triazolam may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide	Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Triazolam.
Midazolam	Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Triazolam.
Naltrexone Injection	Naltrexone Injection The risk or severity of adverse effects can be increased when Naltrexone is combined with Triazolam.
Dexrazoxane Injection	Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Triazolam which could result in a higher serum level.
Milnacipran	Milnacipran The risk or severity of adverse effects can be increased when Triazolam is combined with Milnacipran.
Plerixafor Injection	Plerixafor Injection Triazolam may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine	Fesoterodine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Iloperidone	Iloperidone The risk or severity of adverse effects can be increased when Triazolam is combined with Iloperidone.
Prasugrel	Prasugrel Triazolam may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide	Lacosamide The risk or severity of adverse effects can be increased when Triazolam is combined with Lacosamide.
Everolimus	Everolimus The serum concentration of Triazolam can be increased when it is combined with Everolimus.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone	Dronedarone The metabolism of Triazolam can be decreased when combined with Dronedarone.
AbobotulinumtoxinA Injection	AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Triazolam.
Pralatrexate Injection	Pralatrexate Injection Triazolam may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection	Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Triazolam.
Saxagliptin	Saxagliptin Triazolam may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection	Telavancin Injection Triazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection	Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Triazolam.
Tapentadol	Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Topotecan	Topotecan Triazolam may decrease the excretion rate of Topotecan which could result in a higher serum level.
Golimumab Injection	Golimumab Injection The metabolism of Triazolam can be increased when combined with Golimumab.
Asenapine	Asenapine The risk or severity of adverse effects can be increased when Triazolam is combined with Asenapine.
Vigabatrin	Vigabatrin The risk or severity of adverse effects can be increased when Triazolam is combined with Vigabatrin.
Pitavastatin	Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Pitavastatin.
Levonorgestrel	Levonorgestrel The metabolism of Triazolam can be decreased when combined with Levonorgestrel.
Oxymorphone	Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Triazolam.
Tocilizumab Injection	Tocilizumab Injection The metabolism of Triazolam can be increased when combined with Tocilizumab.
Dalfampridine	Dalfampridine Triazolam may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
IncobotulinumtoxinA Injection	IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Triazolam.
Cabazitaxel Injection	Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Triazolam.
Ceftaroline Injection	Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Lurasidone	Lurasidone The risk or severity of adverse effects can be increased when Triazolam is combined with Lurasidone.
Acetaminophen Injection	Acetaminophen Injection Acetaminophen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Vilazodone	Vilazodone The risk or severity of adverse effects can be increased when Triazolam is combined with Vilazodone.
Ipilimumab Injection	Ipilimumab Injection Triazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection	Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Terbutaline Injection	Terbutaline Injection Terbutaline may decrease the excretion rate of Triazolam which could result in a higher serum level.
Roflumilast	Roflumilast Triazolam may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Cyclophosphamide Injection	Cyclophosphamide Injection The metabolism of Triazolam can be decreased when combined with Cyclophosphamide.
Rivaroxaban	Rivaroxaban Triazolam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib	Ruxolitinib Triazolam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam	Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Triazolam.
Ivacaftor	Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Triazolam.
Deferiprone	Deferiprone Triazolam may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib	Axitinib The metabolism of Axitinib can be decreased when combined with Triazolam.
Crizotinib	Crizotinib The metabolism of Triazolam can be decreased when combined with Crizotinib.
Cabergoline	Cabergoline The risk or severity of adverse effects can be increased when Cabergoline is combined with Triazolam.
Naloxone Injection	Naloxone Injection Triazolam may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan	Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Triazolam.
Fondaparinux Injection	Fondaparinux Injection Fondaparinux may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ezogabine	Ezogabine The risk or severity of adverse effects can be increased when Triazolam is combined with Tiagabine.
Iloprost	Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Iloprost.
Enzalutamide	Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Triazolam.
Mirabegron	Mirabegron Triazolam may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Teduglutide Injection	Teduglutide Injection The serum concentration of Triazolam can be increased when it is combined with Teduglutide.
Alogliptin	Alogliptin Triazolam may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Ponatinib	Ponatinib The metabolism of Ponatinib can be decreased when combined with Triazolam.
Pomalidomide	Pomalidomide The risk or severity of adverse effects can be increased when Triazolam is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Triazolam.
Apixaban	Apixaban The metabolism of Apixaban can be decreased when combined with Triazolam.
Canagliflozin	Canagliflozin Canagliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide	Methazolamide Methazolamide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Trametinib	Trametinib Triazolam may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran	Levomilnacipran The risk or severity of adverse effects can be increased when Triazolam is combined with Levomilnacipran.
Ertapenem Injection	Ertapenem Injection Ertapenem may decrease the excretion rate of Triazolam which could result in a higher serum level.
Vortioxetine	Vortioxetine The risk or severity of adverse effects can be increased when Triazolam is combined with Vortioxetine.
Perampanel	Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Ibrutinib	Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Triazolam.
Ketorolac Injection	Ketorolac Injection Ketorolac may decrease the excretion rate of Triazolam which could result in a higher serum level.
Simeprevir	Simeprevir The serum concentration of Triazolam can be increased when it is combined with Simeprevir.
Sofosbuvir	Sofosbuvir Triazolam may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin	Dapagliflozin Dapagliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast	Apremilast The metabolism of Triazolam can be increased when combined with Apremilast.
Droxidopa	Droxidopa Triazolam may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Siltuximab Injection	Siltuximab Injection The metabolism of Triazolam can be increased when combined with Siltuximab.
Eslicarbazepine	Eslicarbazepine The risk or severity of adverse effects can be increased when Triazolam is combined with Eslicarbazepine.
Testosterone Injection	Testosterone Injection The metabolism of Triazolam can be decreased when combined with Testosterone.
Hydrocodone	Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Suvorexant	Suvorexant Triazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Edoxaban	Edoxaban Triazolam may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Olaparib	Olaparib The metabolism of Olaparib can be decreased when combined with Triazolam.
Methamphetamine	Methamphetamine The risk or severity of adverse effects can be increased when Triazolam is combined with Metamfetamine.
Tasimelteon	Tasimelteon The risk or severity of adverse effects can be increased when Triazolam is combined with Tasimelteon.
Secukinumab Injection	Secukinumab Injection The metabolism of Triazolam can be increased when combined with Secukinumab.
Risperidone Injection	Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Triazolam.
Haloperidol Injection	Haloperidol Injection The risk or severity of CNS depression can be increased when Haloperidol is combined with Triazolam.
Amiloride	Amiloride Amiloride may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan	Macitentan Triazolam may decrease the excretion rate of Macitentan which could result in a higher serum level.
Flibanserin	Flibanserin The risk or severity of adverse effects can be increased when Triazolam is combined with Flibanserin.
Daclatasvir	Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Triazolam.
Brexpiprazole	Brexpiprazole The risk or severity of adverse effects can be increased when Triazolam is combined with Brexpiprazole.
Ziprasidone Injection	Ziprasidone Injection The risk or severity of adverse effects can be increased when Ziprasidone is combined with Triazolam.
Cariprazine	Cariprazine The risk or severity of adverse effects can be increased when Triazolam is combined with Cariprazine.
Penicillin G Procaine Injection	Penicillin G Procaine Injection Triazolam may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline	Eluxadoline The risk or severity of adverse effects can be increased when Eluxadoline is combined with Triazolam.
Trabectedin Injection	Trabectedin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Trabectedin.
Ixazomib	Ixazomib Triazolam may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad	Lesinurad Triazolam may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dexamethasone Injection	Dexamethasone Injection The metabolism of Triazolam can be increased when combined with Dexamethasone.
Brivaracetam Injection	Brivaracetam Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Brivaracetam.
Cobicistat	Cobicistat The metabolism of Triazolam can be decreased when combined with Cobicistat.
Pimavanserin	Pimavanserin The risk or severity of adverse effects can be increased when Triazolam is combined with Pimavanserin.
Diphenhydramine Injection	Diphenhydramine Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Diphenhydramine.
Furosemide Injection	Furosemide Injection Furosemide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib	Rucaparib The metabolism of Triazolam can be decreased when combined with Rucaparib.
Lixisenatide Injection	Lixisenatide Injection Triazolam may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia)	Doxepin (Insomnia) Triazolam may increase the central nervous system depressant (CNS depressant) activities of Doxepin.
Deutetrabenazine	Deutetrabenazine The risk or severity of sedation and somnolence can be increased when Triazolam is combined with Deutetrabenazine.
Valbenazine	Valbenazine Triazolam may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort	Deflazacort The metabolism of Triazolam can be increased when combined with Deflazacort.
Safinamide	Safinamide The metabolism of Triazolam can be decreased when combined with Safinamide.
Naldemedine	Naldemedine Triazolam may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin	Midostaurin The metabolism of Triazolam can be increased when combined with Midostaurin.
Benznidazole	Benznidazole Triazolam may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection	Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Triazolam.
Delafloxacin	Delafloxacin Triazolam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Acalabrutinib	Acalabrutinib The metabolism of Triazolam can be decreased when combined with Acalabrutinib.
Letermovir	Letermovir The metabolism of Triazolam can be decreased when combined with Letermovir.
Tetrabenazine	Tetrabenazine The risk or severity of sedation and somnolence can be increased when Triazolam is combined with Tetrabenazine.
Ertugliflozin	Ertugliflozin Ertugliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection	Buprenorphine Injection Triazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide	Apalutamide Triazolam may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Penicillamine	Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Triazolam.
Baricitinib	Baricitinib Triazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine	Lofexidine The therapeutic efficacy of Triazolam can be increased when used in combination with Lofexidine.
Plazomicin Injection	Plazomicin Injection Triazolam may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Doravirine	Doravirine The metabolism of Doravirine can be decreased when combined with Triazolam.
Cannabidiol	Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Triazolam.
Stiripentol	Stiripentol The risk or severity of adverse effects can be increased when Triazolam is combined with Stiripentol.
Lorlatinib	Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Triazolam.
Paclitaxel (with albumin) Injection	Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Triazolam.
Prucalopride	Prucalopride Triazolam may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The metabolism of Triazolam can be increased when combined with Emapalumab.
Acyclovir Ophthalmic	Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Brexanolone Injection	Brexanolone Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Brexanolone.
Cladribine	Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Triazolam.
Solriamfetol	Solriamfetol The risk or severity of adverse effects can be increased when Triazolam is combined with Solriamfetol.
Istradefylline	Istradefylline The metabolism of Istradefylline can be decreased when combined with Triazolam.
Pitolisant	Pitolisant The serum concentration of Triazolam can be decreased when it is combined with Pitolisant.
Phenytoin Injection	Phenytoin Injection The risk or severity of adverse effects can be increased when Phenytoin is combined with Triazolam.
Fosphenytoin Injection	Fosphenytoin Injection The risk or severity of adverse effects can be increased when Triazolam is combined with Fosphenytoin.
Lumateperone	Lumateperone The risk or severity of adverse effects can be increased when Triazolam is combined with Lumateperone.
Lasmiditan	Lasmiditan The risk or severity of adverse effects can be increased when Triazolam is combined with Lasmiditan.
Cenobamate	Cenobamate The serum concentration of Triazolam can be decreased when it is combined with Cenobamate.
Selumetinib	Selumetinib The metabolism of Selumetinib can be decreased when combined with Triazolam.
Tucatinib	Tucatinib The metabolism of Tucatinib can be decreased when combined with Triazolam.
Lemborexant	Lemborexant The risk or severity of adverse effects can be increased when Triazolam is combined with Lemborexant.
Fenfluramine	Fenfluramine The risk or severity of adverse effects can be increased when Fenfluramine is combined with Triazolam.
Pralsetinib	Pralsetinib The metabolism of Triazolam can be decreased when combined with Pralsetinib.
Satralizumab-mwge Injection	Satralizumab-mwge Injection The serum concentration of Triazolam can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine	Viloxazine The risk or severity of adverse effects can be increased when Triazolam is combined with Viloxazine.
Tobramycin Injection	Tobramycin Injection Tobramycin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Theophylline	Theophylline The therapeutic efficacy of Triazolam can be decreased when used in combination with Theophylline.
Fenoprofen	Fenoprofen Fenoprofen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Indomethacin	Indomethacin Indomethacin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Mefenamic Acid	Mefenamic Acid Mefenamic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Naproxen	Naproxen Naproxen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tolmetin	Tolmetin Tolmetin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Sulindac	Sulindac Sulindac may decrease the excretion rate of Triazolam which could result in a higher serum level.
Trazodone	Trazodone The risk or severity of adverse effects can be increased when Trazodone is combined with Triazolam.
Isotretinoin	Isotretinoin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Isotretinoin.
Sucralfate	Sucralfate Sucralfate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Floxuridine	Floxuridine Floxuridine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Phenobarbital	Phenobarbital The risk or severity of adverse effects can be increased when Triazolam is combined with Phenobarbital.
Metaxalone	Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Triazolam.
Methotrexate Injection	Methotrexate Injection Methotrexate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Levorphanol	Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Triazolam.
Primidone	Primidone The risk or severity of adverse effects can be increased when Primidone is combined with Triazolam.
Methsuximide	Methsuximide The risk or severity of adverse effects can be increased when Triazolam is combined with Methsuximide.
Diethylpropion	Diethylpropion The risk or severity of adverse effects can be increased when Triazolam is combined with Diethylpropion.
Chlorpromazine	Chlorpromazine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.
Diazepam	Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Triazolam.
Oxazepam	Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Triazolam.
Flurazepam	Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Triazolam.
Clorazepate	Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Triazolam.
Lorazepam	Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Triazolam.
Carmustine	Carmustine Carmustine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Amantadine	Amantadine Triazolam may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine	Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Triazolam.
Meprobamate	Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Triazolam.
Chlordiazepoxide	Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Triazolam.
Bromocriptine	Bromocriptine The risk or severity of adverse effects can be increased when Triazolam is combined with Bromocriptine.
Tranylcypromine	Tranylcypromine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Triazolam.
Phenelzine	Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Triazolam.
Procarbazine	Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Procarbazine.
Ergoloid Mesylates	Ergoloid Mesylates The risk or severity of adverse effects can be increased when Triazolam is combined with Ergoloid mesylate.
Tetracycline	Tetracycline Tetracycline may decrease the excretion rate of Triazolam which could result in a higher serum level.
Minocycline	Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Prochlorperazine	Prochlorperazine The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Triazolam.
Thioridazine	Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Triazolam.
Trifluoperazine	Trifluoperazine The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Triazolam.
Bleomycin	Bleomycin Bleomycin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dapsone	Dapsone The metabolism of Triazolam can be decreased when combined with Dapsone.
Sulfadiazine	Sulfadiazine Sulfadiazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Oxycodone	Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Triazolam.
Methadone	Methadone Triazolam may increase the central nervous system depressant (CNS depressant) activities of Methadone.
Oxybutynin	Oxybutynin Triazolam may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine	Benztropine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
Maprotiline	Maprotiline The risk or severity of adverse effects can be increased when Triazolam is combined with Maprotiline.
Ibuprofen	Ibuprofen Ibuprofen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Trihexyphenidyl	Trihexyphenidyl Triazolam may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine	Orphenadrine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine	Perphenazine The risk or severity of adverse effects can be increased when Perphenazine is combined with Triazolam.
Azathioprine	Azathioprine Triazolam may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Fluphenazine	Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Triazolam.
Methylphenidate	Methylphenidate Methylphenidate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Amoxapine	Amoxapine The risk or severity of adverse effects can be increased when Amoxapine is combined with Triazolam.
Sulfasalazine	Sulfasalazine Sulfasalazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Hydrocortisone	Hydrocortisone The metabolism of Triazolam can be decreased when combined with Hydrocortisone.
Cytarabine	Cytarabine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Cytarabine.
Phenazopyridine	Phenazopyridine Phenazopyridine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Carbamazepine	Carbamazepine The metabolism of Triazolam can be decreased when combined with Carbamazepine.
Molindone	Molindone The risk or severity of adverse effects can be increased when Triazolam is combined with Molindone.
Methyldopa	Methyldopa The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Methyldopa.
Clonidine	Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Triazolam.
Hydralazine	Hydralazine Triazolam may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine	Cimetidine The metabolism of Triazolam can be decreased when combined with Cimetidine.
Gentamicin Injection	Gentamicin Injection Gentamicin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Warfarin	Warfarin Warfarin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Clonazepam	Clonazepam The risk or severity of adverse effects can be increased when Triazolam is combined with Clonazepam.
Promethazine	Promethazine The risk or severity of adverse effects can be increased when Triazolam is combined with Promethazine.
Meclofenamate	Meclofenamate Meclofenamic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Daunorubicin	Daunorubicin The metabolism of Triazolam can be increased when combined with Daunorubicin.
Nitrofurantoin	Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Digoxin	Digoxin Triazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine	Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Triazolam.
Chloroquine	Chloroquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Triazolam.
Quinine	Quinine The risk or severity of adverse effects can be increased when Quinine is combined with Triazolam.
Ethosuximide	Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Triazolam.
Triamterene	Triamterene Triamterene may decrease the excretion rate of Triazolam which could result in a higher serum level.
Chlorothiazide	Chlorothiazide Chlorothiazide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone	Chlorthalidone Chlorthalidone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone	Metolazone Metolazone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide	Isosorbide Isosorbide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection	Clindamycin Injection The serum concentration of Clindamycin can be increased when it is combined with Triazolam.
Secobarbital	Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Triazolam.
Desipramine	Desipramine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Desipramine.
Amitriptyline	Amitriptyline Triazolam may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Imipramine	Imipramine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Imipramine.
Probenecid	Probenecid Triazolam may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine	Quinidine The metabolism of Triazolam can be decreased when combined with Quinidine.
Procainamide	Procainamide Triazolam may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid	Isoniazid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Isoniazid.
Pyrazinamide	Pyrazinamide Pyrazinamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Rifampin	Rifampin The metabolism of Triazolam can be increased when combined with Rifampicin.
Disopyramide	Disopyramide Triazolam may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.
Valproic Acid	Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Triazolam.
Tamoxifen	Tamoxifen The metabolism of Triazolam can be decreased when combined with Tamoxifen.
Butabarbital	Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Triazolam.
Liothyronine	Liothyronine Liothyronine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Methimazole	Methimazole Methimazole may decrease the excretion rate of Triazolam which could result in a higher serum level.
Propylthiouracil	Propylthiouracil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Triazolam.
Chlorpropamide	Chlorpropamide Chlorpropamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tolbutamide	Tolbutamide Triazolam may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
Tolazamide	Tolazamide Tolazamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dextromethorphan	Dextromethorphan The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Triazolam.
Cyclobenzaprine	Cyclobenzaprine The risk or severity of CNS depression can be increased when Triazolam is combined with Cyclobenzaprine.
Niacin	Niacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Triazolam.
Baclofen	Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Triazolam.
Doxylamine	Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Cyproheptadine	Cyproheptadine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.
Clemastine	Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Triazolam.
Chlorpheniramine	Chlorpheniramine The risk or severity of adverse effects can be increased when Triazolam is combined with Chlorpheniramine.
Brompheniramine	Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Triazolam.
Meclizine	Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Triazolam.
Ethambutol	Ethambutol Ethambutol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Methyclothiazide	Methyclothiazide Methyclothiazide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide	Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dantrolene	Dantrolene The risk or severity of adverse effects can be increased when Triazolam is combined with Dantrolene.
Chlorzoxazone	Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Triazolam.
Carisoprodol	Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Triazolam.
Methocarbamol	Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Triazolam.
Pyridoxine	Pyridoxine Pyridoxine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Folic Acid	Folic Acid Folic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Disulfiram	Disulfiram The metabolism of Triazolam can be decreased when combined with Disulfiram.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) Propranolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nortriptyline	Nortriptyline Triazolam may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.
Spironolactone	Spironolactone Spironolactone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection	Amphotericin B Injection Amphotericin B may decrease the excretion rate of Triazolam which could result in a higher serum level.
Mercaptopurine	Mercaptopurine The therapeutic efficacy of Triazolam can be decreased when used in combination with Mercaptopurine.
Phytonadione	Phytonadione Triazolam may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection	Amikacin Injection Amikacin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nadolol	Nadolol Triazolam may decrease the excretion rate of Nadolol which could result in a higher serum level.
Butorphanol Injection	Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Triazolam.
Nalbuphine Injection	Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Triazolam.
Allopurinol	Allopurinol Allopurinol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Trimethobenzamide	Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Triazolam.
Flavoxate	Flavoxate Triazolam may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Colchicine	Colchicine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Colchicine.
Cefaclor	Cefaclor Cefaclor may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefadroxil	Cefadroxil Cefadroxil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefazolin Injection	Cefazolin Injection Cefazolin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cephalexin	Cephalexin Cephalexin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefoxitin Injection	Cefoxitin Injection Cefoxitin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dacarbazine	Dacarbazine Dacarbazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Acetazolamide	Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Triazolam.
Cefotaxime Injection	Cefotaxime Injection Cefotaxime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Calcitonin Salmon Injection	Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ketoconazole	Ketoconazole The metabolism of Triazolam can be decreased when combined with Ketoconazole.
Pyrantel	Pyrantel The risk or severity of adverse effects can be increased when Triazolam is combined with Pyrantel.
Vincristine Injection	Vincristine Injection The metabolism of Triazolam can be decreased when combined with Vincristine.
Captopril	Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Captopril.
Ethacrynic Acid	Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Colistimethate Injection	Colistimethate Injection Colistimethate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Metoprolol	Metoprolol Metoprolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Hydroxyzine	Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Thiothixene	Thiothixene The risk or severity of adverse effects can be increased when Triazolam is combined with Thiothixene.
Aspirin	Aspirin Acetylsalicylic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Salsalate	Salsalate Salsalate may decrease the excretion rate of Triazolam which could result in a higher serum level.
Alprazolam	Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Triazolam.
Temazepam	Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Triazolam.
Dicyclomine	Dicyclomine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine	Hyoscyamine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline	Propantheline Triazolam may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim	Trimethoprim The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Triazolam.
Diltiazem	Diltiazem The metabolism of Triazolam can be decreased when combined with Diltiazem.
Nifedipine	Nifedipine The metabolism of Nifedipine can be decreased when combined with Triazolam.
Timolol	Timolol Timolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Verapamil	Verapamil The metabolism of Triazolam can be decreased when combined with Verapamil.
Pindolol	Pindolol The risk or severity of adverse effects can be increased when Triazolam is combined with Pindolol.
Cisplatin Injection	Cisplatin Injection Triazolam may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal	Diflunisal Diflunisal may decrease the excretion rate of Triazolam which could result in a higher serum level.
Piroxicam	Piroxicam Piroxicam may decrease the excretion rate of Triazolam which could result in a higher serum level.
Bumetanide	Bumetanide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Triazolam.
Etoposide	Etoposide The metabolism of Triazolam can be decreased when combined with Etoposide.
Glyburide	Glyburide The metabolism of Glyburide can be decreased when combined with Triazolam.
Glipizide	Glipizide Triazolam may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide	Indapamide Indapamide may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin	Amoxicillin Triazolam may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection	Oxacillin Injection Oxacillin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Pentoxifylline	Pentoxifylline The therapeutic efficacy of Triazolam can be decreased when used in combination with Pentoxifylline.
Pentamidine Injection	Pentamidine Injection Pentamidine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ceftriaxone Injection	Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Labetalol	Labetalol Labetalol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Auranofin	Auranofin Triazolam may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection	Leuprolide Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Triazolam.
Gemfibrozil	Gemfibrozil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Gemfibrozil.
Dipivefrin Ophthalmic	Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ceftazidime Injection	Ceftazidime Injection Ceftazidime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ketoprofen	Ketoprofen Ketoprofen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefotetan Injection	Cefotetan Injection Cefotetan may decrease the excretion rate of Triazolam which could result in a higher serum level.
Pimozide	Pimozide The metabolism of Pimozide can be decreased when combined with Triazolam.
Enalapril	Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Triazolam.
Flurbiprofen	Flurbiprofen Flurbiprofen may decrease the excretion rate of Triazolam which could result in a higher serum level.
Amiodarone	Amiodarone The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Amiodarone.
Aztreonam Injection	Aztreonam Injection Aztreonam may decrease the excretion rate of Triazolam which could result in a higher serum level.
Buspirone	Buspirone Buspirone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Lovastatin	Lovastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Triazolam.
Ciprofloxacin	Ciprofloxacin The metabolism of Triazolam can be decreased when combined with Ciprofloxacin.
Mesalamine	Mesalamine Mesalazine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Diclofenac	Diclofenac Diclofenac may decrease the excretion rate of Triazolam which could result in a higher serum level.
Fluoxetine	Fluoxetine The serum concentration of Triazolam can be increased when it is combined with Fluoxetine.
Clozapine	Clozapine The risk or severity of adverse effects can be increased when Triazolam is combined with Clozapine.
Estazolam	Estazolam The risk or severity of adverse effects can be increased when Triazolam is combined with Estazolam.
Ofloxacin	Ofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Ofloxacin.
Didanosine	Didanosine Triazolam may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection	Pentostatin Injection Pentostatin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Clarithromycin	Clarithromycin The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.
Etodolac	Etodolac Etodolac may decrease the excretion rate of Triazolam which could result in a higher serum level.
Felodipine	Felodipine The metabolism of Felodipine can be decreased when combined with Triazolam.
Fosinopril	Fosinopril Fosinopril may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nabumetone	Nabumetone Nabumetone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Pravastatin	Pravastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Triazolam.
Simvastatin	Simvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Simvastatin is combined with Triazolam.
Teniposide Injection	Teniposide Injection The metabolism of Triazolam can be decreased when combined with Teniposide.
Itraconazole	Itraconazole The metabolism of Triazolam can be decreased when combined with Itraconazole.
Lisinopril	Lisinopril Lisinopril may decrease the excretion rate of Triazolam which could result in a higher serum level.
Oxaprozin	Oxaprozin Oxaprozin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Bisoprolol	Bisoprolol Bisoprolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Zolpidem	Zolpidem Triazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Isradipine	Isradipine Isradipine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cisapride	Cisapride The risk or severity of adverse effects can be increased when Cisapride is combined with Triazolam.
Gabapentin	Gabapentin The risk or severity of adverse effects can be increased when Triazolam is combined with Gabapentin.
Fluvastatin	Fluvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Fluvastatin.
Venlafaxine	Venlafaxine The risk or severity of adverse effects can be increased when Venlafaxine is combined with Triazolam.
Nizatidine	Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Triazolam.
Stavudine	Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Triazolam.
Fluvoxamine	Fluvoxamine The risk or severity of adverse effects can be increased when Triazolam is combined with Fluvoxamine.
Nefazodone	Nefazodone The risk or severity of adverse effects can be increased when Triazolam is combined with Nefazodone.
Lamotrigine	Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Triazolam.
Valacyclovir	Valacyclovir Valaciclovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tramadol	Tramadol The risk or severity of CNS depression can be increased when Tramadol is combined with Triazolam.
Carboplatin Injection	Carboplatin Injection Carboplatin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ifosfamide Injection	Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Triazolam.
Nicardipine	Nicardipine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.
Bupropion	Bupropion The risk or severity of adverse effects can be increased when Triazolam is combined with Bupropion.
Ticlopidine	Ticlopidine Ticlopidine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Saquinavir	Saquinavir The serum concentration of Triazolam can be increased when it is combined with Saquinavir.
Metformin	Metformin Metformin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nisoldipine	Nisoldipine Nisoldipine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Lamivudine	Lamivudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Triazolam.
Riluzole	Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Triazolam.
Acarbose	Acarbose Acarbose may decrease the excretion rate of Triazolam which could result in a higher serum level.
Gemcitabine Injection	Gemcitabine Injection Gemcitabine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Indinavir	Indinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Triazolam.
Ritonavir	Ritonavir The serum concentration of Triazolam can be increased when it is combined with Ritonavir.
Docetaxel Injection	Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Triazolam.
Cidofovir Injection	Cidofovir Injection Cidofovir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Meropenem Injection	Meropenem Injection Meropenem may decrease the excretion rate of Triazolam which could result in a higher serum level.
Clomipramine	Clomipramine The risk or severity of adverse effects can be increased when Triazolam is combined with Clomipramine.
Fosfomycin	Fosfomycin Fosfomycin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Mirtazapine	Mirtazapine Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Triazolam.
Topiramate	Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Triazolam.
Pramipexole	Pramipexole Triazolam may increase the sedative activities of Pramipexole.
Donepezil	Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Triazolam.
Nelfinavir	Nelfinavir The metabolism of Triazolam can be decreased when combined with Nelfinavir.
Nilutamide	Nilutamide Nilutamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Flutamide	Flutamide Flutamide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Selegiline	Selegiline The risk or severity of adverse effects can be increased when Triazolam is combined with Selegiline.
Sertraline	Sertraline The risk or severity of adverse effects can be increased when Triazolam is combined with Sertraline.
Letrozole	Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Letrozole.
Tamsulosin	Tamsulosin Tamsulosin may decrease the excretion rate of Triazolam which could result in a higher serum level.
Ropinirole	Ropinirole Triazolam may increase the sedative activities of Ropinirole.
Finasteride	Finasteride The metabolism of Finasteride can be decreased when combined with Triazolam.
Quetiapine	Quetiapine The risk or severity of adverse effects can be increased when Triazolam is combined with Quetiapine.
Cefepime Injection	Cefepime Injection Cefepime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefprozil	Cefprozil Cefprozil may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cefpodoxime	Cefpodoxime Cefpodoxime may decrease the excretion rate of Triazolam which could result in a higher serum level.
Cetirizine	Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Triazolam.
Paroxetine	Paroxetine The risk or severity of adverse effects can be increased when Triazolam is combined with Paroxetine.
Tolcapone	Tolcapone The risk or severity of adverse effects can be increased when Tolcapone is combined with Triazolam.
Citalopram	Citalopram The risk or severity of adverse effects can be increased when Triazolam is combined with Citalopram.
Capecitabine	Capecitabine Triazolam may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz	Efavirenz The risk or severity of adverse effects can be increased when Efavirenz is combined with Triazolam.
Abacavir	Abacavir Triazolam may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil	Sildenafil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Triazolam.
Celecoxib	Celecoxib Celecoxib may decrease the excretion rate of Triazolam which could result in a higher serum level.
Rosiglitazone	Rosiglitazone Rosiglitazone may decrease the excretion rate of Triazolam which could result in a higher serum level.
Tolterodine	Tolterodine Triazolam may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide	Thalidomide Triazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir	Oseltamivir Oseltamivir may decrease the excretion rate of Triazolam which could result in a higher serum level.
Balsalazide	Balsalazide Balsalazide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Nateglinide	Nateglinide Nateglinide may decrease the excretion rate of Triazolam which could result in a higher serum level.
Levetiracetam	Levetiracetam The risk or severity of adverse effects can be increased when Levetiracetam is combined with Triazolam.
Rabeprazole	Rabeprazole Triazolam may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
Terbinafine	Terbinafine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Triazolam.